BATM* (BVC): Trading update reveals revenue delays (CORP) |Abzena (ABZA): Trading update (BUY) |LiDCO* (LID): Board changes (CORP) |OptiBiotix* (OPTI): Launch of cholesterol lowering products (CORP)
01 Mar 2017
Morning Note
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
01 Mar 2017 -
Author:
Mark Brewer | Cavendish Research -
Pages:
6
BATM* (BVC): Trading update reveals revenue delays (CORP) |Abzena (ABZA): Trading update (BUY) |LiDCO* (LID): Board changes (CORP) |OptiBiotix* (OPTI): Launch of cholesterol lowering products (CORP)